CTN clinical coordinating center support POP 08/14/20-08/13/21
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,744,212
Award facts
- Opportunity
-
- Clinical Coordinating Center for NIDA’s Clinical Trials Network Pre-Solicitation · Posted Nov 12, 2019
- Clinical Coordinating Center for NIDA’s Clinical Trials Network Award Notice · Posted Aug 14, 2020
- Contract value 100% obligated
- $3,744,211.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$319,858 | |
| Original award | $4,064,070 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company, to provide clinical coordinating center support services. The contract has a ceiling value of $3,744,211.88 and a period of performance from August 14, 2020 to August 13, 2021. The contract is not set aside for any specific business type.
The Emmes Company LLC is a global clinical research organization that specializes in providing a wide range of services to federal agencies, particularly the National Institutes of Health (NIH) and its various institutes, including biostatistical analysis, epidemiological studies, data management, clinical trial coordination, regulatory support, and operational oversight for large-scale research programs. The company has secured numerous prime federal contract and grant awards from various NIH institutes, demonstrating its capabilities across a broad spectrum of research domains.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 14, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $3,744,212 on 75N95020F00001.
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under 75N95020D00012, an indefinite delivery contract.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award